Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)

(2011) C. Lascols et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

(2011) Timothy R Walsh et al.   LANCET INFECTIOUS DISEASES

Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae

(2010) David M. Livermore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Potentiation of Carbapenems with ME1071, a Novel Metallo- -Lactamase Inhibitor, against Metallo- -Lactamase- Producing Pseudomonas aeruginosa Clinical Isolates

(2010) Y. Ishii et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Spread of OXA-48-Encoding Plasmid in Turkey and Beyond

(2010) A. Carrer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae

(2010) Karen Bush   CURRENT OPINION IN MICROBIOLOGY

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

(2010) Karthikeyan K Kumarasamy et al.   LANCET INFECTIOUS DISEASES

Metallo-β-lactamase inhibitory activity of phthalic acid derivatives

(2009) Yukiko Hiraiwa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES